Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Tempest Therapeutics Inc (TPST)

Tempest Therapeutics Inc (TPST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 99,743
  • Shares Outstanding, K 6,703
  • Annual Sales, $ 0 K
  • Annual Income, $ -36,410 K
  • 60-Month Beta 0.49
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.05
Trade TPST with:

Options Overview Details

View History
  • Implied Volatility 0.00%
  • Historical Volatility 46.67%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 0.00% on 09/28/21
  • IV Low 0.00% on 09/28/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 0
  • Open Int (30-Day) 94

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -1.10
  • Number of Estimates 2
  • High Estimate -1.07
  • Low Estimate -1.12
  • Prior Year -5.10
  • Growth Rate Est. (year over year) +78.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.49 +7.41%
on 09/20/21
16.39 -11.59%
on 09/17/21
-0.38 (-2.56%)
since 08/27/21
3-Month
10.39 +39.53%
on 07/08/21
41.00 -64.66%
on 07/12/21
+1.13 (+8.46%)
since 06/28/21
52-Week
10.39 +39.53%
on 07/08/21
41.55 -65.13%
on 02/10/21
-8.46 (-36.86%)
since 09/28/20

Most Recent Stories

More News
Tempest Reports Second Quarter 2021 Financial Results and Provides Corporate Highlights

EQNX::TICKER_START (NASDAQ:TPST), EQNX::TICKER_END

TPST : 14.49 (-2.62%)
Tempest Announces Appointment of Ronit Simantov, M.D. to its Board of Directors

Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest"), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, today...

TPST : 14.49 (-2.62%)
Thinking about buying stock in Verb Technology, Casper Sleep, Millendo Therapeutics, Lipocine, or Hepion Pharmaceuticals?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VERB, CSPR, TPST, LPCN, and HEPA.

LPCN : 1.1000 (-0.90%)
HEPA : 1.5500 (-1.90%)
TPST : 14.49 (-2.62%)
VERB : 1.7800 (-3.78%)
CSPR : 4.79 (-4.01%)
Thinking about buying stock in Cemtrex, Millendo Therapeutics, Exela Technologies, OrganiGram, or electroCore?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CETX, TPST, XELA, OGI, and ECOR.

CETX : 1.1600 (-3.33%)
XELA : 1.94 (-6.28%)
ECOR : 1.1200 (-3.45%)
OGI : 2.38 (-3.25%)
TPST : 14.49 (-2.62%)
Thinking about buying stock in Tempest Therapeutics, Cemtrex, Exela Technologies, Aethlon Medical, or Bridgeline Digital?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TPST, CETX, XELA, AEMD, and BLIN.

AEMD : 4.23 (+1.68%)
BLIN : 4.11 (-3.75%)
CETX : 1.1600 (-3.33%)
XELA : 1.94 (-6.28%)
TPST : 14.49 (-2.62%)
Tempest to Participate in William Blair 2021 Biotech Focus Conference

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, today announced...

TPST : 14.49 (-2.62%)
Tempest Announces Appointment of Christine Pellizzari to its Board of Directors

Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest"), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, today...

TPST : 14.49 (-2.62%)
Tempest Closes Merger with Millendo and Completes PIPE Financing

Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest"), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, announced...

TPST : 14.49 (-2.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.

See More

Key Turning Points

3rd Resistance Point 15.21
2nd Resistance Point 15.03
1st Resistance Point 14.76
Last Price 14.49
1st Support Level 14.31
2nd Support Level 14.13
3rd Support Level 13.86

See More

52-Week High 41.55
Fibonacci 61.8% 29.64
Fibonacci 50% 25.97
Fibonacci 38.2% 22.29
Last Price 14.49
52-Week Low 10.39

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar